Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

974

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Crohn's DiseaseUlcerative Colitis
Trial Locations (24)

10021

Icahn School of Medicine at Mount Sinai, New York

10028

Lenox Hill Hospital, New York

15213

University of Pittsburth, Pittsburgh

17033

Penn State College of Medicine, Hershey

19104

The University of Pennsylvania, Philadelphia

21201

University of Maryland School of Medicine, Baltimore

27157

Wake Forest School of Medicine, Winston-Salem

27599

University of North Carolina, Chapel Hill

32608

University of Florida College of Medicine, Gainesville

33331

Cleveland Clinic Florida, Weston

44106

University Hospitals Case Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

48109

University of Michigan, Ann Arbor

55905

Mayo Clinic Rochester, Rochester

60637

The University of Chicago, Chicago

61801

Carle Foundation Hospital, Urbana

80045

University of Colorado Anschutz Medical Campus, Aurora

85259

Mayo Clinic Arizona, Scottsdale

90048

Cedars-Sinai Medical Center, Los Angeles

94115

University of California San Francisco, San Francisco

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Inc., Boston

02118

Boston Medical Center, Boston

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02054533 - Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter